Timpel

What Timpel does

Timpel is a privately held medical technology company headquartered in São Paulo, Brazil, that develops and commercializes the ENLIGHT precision ventilation monitoring system for critical care settings. The company's core product is the ENLIGHT 2100 bedside device, which uses Electrical Impedance Tomography (EIT) — a non-invasive, radiation-free modality that applies high-frequency, low-intensity electrical signals via a chest belt with embedded electrodes to generate real-time images of pulmonary ventilation and perfusion. Around the ENLIGHT 2100 platform, Timpel offers a suite of clinical decision support modules, including a Ventilation Screen for dynamic imaging, a PEEP Titration Tool, a Trends Screen, an Asynchrony Tool, and a V/Q Tool, plus a dedicated Neonatal Module. The technology is positioned as the first system to bring precision medicine to bedside mechanical ventilation, enabling clinicians to personalize ventilator settings based on individual patient pulmonary heterogeneity and to detect complications such as asynchronies or V/Q mismatch in real time.

Timpel generates revenue through two primary streams: hardware sales of the ENLIGHT 2100 device (including the electrode belt) and professional services via Timpel Academy, its training platform, and ongoing technical support. Pricing is not publicly disclosed; customers contact the company directly via a sales inquiry form segmented by continent or via regional email/phone lines. The company serves a single vertical — acute care hospitals and intensive care units — through a direct enterprise field sales motion with regional offices in São Paulo (HQ), Eindhoven, Netherlands (European regional office), and San Diego, California (North American regional office).

The company is backed by FinHealth, a healthcare-specialist private equity and venture capital firm, and has received R&D support from Brazilian public funding agencies FAPESP and FINEP, as well as IDB Lab (2020). Timpel also operates a wholly-owned subsidiary, Timpel Academy, dedicated to clinical education.

Name

Timpel

Legal name

Timpel Medical

Website

https://timpel.com.br

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1–10 employees

Short description

Timpel is a Brazilian medical technology company that develops the ENLIGHT 2100, a non-invasive Electrical Impedance Tomography (EIT) bedside system for real-time precision ventilation monitoring in hospital ICUs, with regional offices in Brazil, the Netherlands, and the USA.

Ownership category

akta.pro rank

Product category

Critical Care Ventilation Monitoring (Medical Devices)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Surgical and Medical Instrument Manufacturing (339112)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industries

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)

Keywords

• Precision ventilation monitoring
• Electrical impedance tomography
• Mechanical ventilation support
• ICU clinical decision support
• Radiation-free lung imaging

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Device Hardware Sales: Sale of ENLIGHT 2100 and ENLIGHT medical monitoring systems, including the hardware belt with embedded electrodes for electrical impedance tomography monitoring.
2. Clinical Support and Training Services: Timpel Academy provides training services. Ongoing technical support and service requests through dedicated service email.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Timpel develops, manufactures, and sells the ENLIGHT 2100 precision ventilation monitoring system — a bedside medical device based on proprietary Electrical Impedance Tomography (EIT) technology that delivers non-invasive, radiation-free, real-time imaging of lung ventilation and perfusion. The system integrates clinical decision support modules (PEEP titration, asynchrony detection, V/Q analysis, trends, neonatal monitoring) and is sold with accompanying clinical training services (Timpel Academy) to hospitals and intensive care units worldwide.

Product overview

Timpel offers the ENLIGHT precision ventilation system, which consists of the ENLIGHT 2100 as the core hardware/software platform and multiple integrated clinical decision support modules. The system is built on Electrical Impedance Tomography (EIT) technology, providing non-invasive, radiation-free real-time lung imaging at the bedside. The portfolio includes the main ENLIGHT 2100 product along with specialized tools: Ventilation Screen for dynamic imaging, PEEP Titration Tool for optimizing positive end-expiratory pressure, Trends Screen for data visualization, Asynchrony Tool for detecting ventilator-patient dyssynchrony, V/Q Tool for ventilation-perfusion monitoring, and dedicated Neonatal Module. These modules work together within the unified ENLIGHT platform to deliver personalized, goal-oriented, real-time precision ventilation from intubation to weaning.

Differentiator

Problem solved

Functional benefit

Brands

• ENLIGHT: A bedside expert system for precision ventilation that provides real-time visualization of lung ventilation and perfusion, featuring tools for PEEP titration, trend monitoring, asynchrony detection, and V/Q matching.
• ENLIGHT 2100
• Timpel Academy

Products and services

• ENLIGHT 2100 A bedside expert medical device for precision ventilation that provides real-time, non-invasive, radiation-free visualization of lung ventilation and perfusion for mechanically ventilated patients. Built on proprietary Electrical Impedance Tomography (EIT) technology with an embedded-electrode chest belt and clinically validated imaging algorithm. Features intuitive integrated clinical decision support tools, high temporal resolution imaging, mobility across patients, ergonomic belts, and applicability for pediatric, adult, and neonatal use. Sold to acute care hospitals and ICU units.
• Timpel Academy Educational and clinical training service for medical professionals on ENLIGHT system usage and clinical applications in precision ventilation. Operated as a wholly owned subsidiary of Timpel Medical.

Quantifiable outcome

• Problems can be treated before they become more serious complications
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature7 records

Scale indicators1 record

Recent moves1 record

Expansion highlights5 records

Broad incumbents

• Vyaire Medical: Pure-play respiratory care company offering ventilators and related consumables. Vyaire is directly comparable in ICU ventilation and competes for the same hospital capital and consumables budgets as Timpel's ENLIGHT.
• Drägerwerk: Global leader in mechanical ventilation and patient monitoring with a broad ICU portfolio. Dräger competes with Timpel in the ICU ventilation space and has the scale to bundle or replicate EIT-style monitoring features within its ventilator ecosystem.
• Hamilton Medical: Major ICU ventilator manufacturer serving hospitals worldwide. Through its Swisstom acquisition, Hamilton is the closest direct EIT-monitoring competitor to Timpel, making it the most relevant incumbent comparable.
• GE HealthCare: Large diversified medical device and monitoring company with ICU ventilator and patient monitoring products. GE competes in the same hospital ICU purchasing decisions as Timpel and could integrate precision ventilation features into its broader portfolio.
• Philips (Philips Healthcare): Global medical technology company with respiratory care and patient monitoring offerings. Philips competes in ICU and critical care settings where Timpel sells ENLIGHT and has the resources to add precision ventilation capabilities.
• Getinge (Maquet): Major provider of ICU ventilators and surgical/perioperative solutions. Getinge is a relevant incumbent comparable for hospital purchasing in mechanical ventilation and critical care monitoring.
• Mindray: Global medical device manufacturer with ventilator and patient monitoring products serving hospitals worldwide. Mindray competes in ICU equipment budgets and is increasingly present in emerging markets where Timpel also operates.
• Medtronic: Global medical device leader with respiratory and patient monitoring offerings (including ventilation and airway management). Medtronic competes in the same ICU purchasing decisions and has the scale to expand precision ventilation capabilities.
• Nihon Kohden: Japanese patient monitoring specialist with ICU and ventilation-adjacent products. Nihon Kohden competes in the same hospital monitoring purchasing decisions and is exploring lung function/EIT-adjacent technologies.

Emerging players

• Sentec (BD): Specialist in non-invasive respiratory monitoring (tcCO2, SpO2) for neonatal and adult critical care. Now part of BD, Sentec overlaps with Timpel in non-invasive bedside respiratory monitoring and neonatal use cases.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@timpelmedical
• LinkedInlinkedin.com/company/timpel

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Timpel